Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: SOLIDARITY Trial

WHO Declares Drugs Like Remdesivir Don’t Reduce Mortality or Even Duration of Hospitalization: Other Data Refutes This Position However

The World Health Organization (WHO) has shared interim results from the international, open-label trial published recently in the New England […]

WHO Declares Drugs Like Remdesivir Don’t Reduce Mortality or Even Duration of Hospitalization Other Data Refutes This Position However
1 month ago
Share

World Health Organization Solidarity Trial: Remdesivir & Others of No Real Therapeutic Benefit

The World’s Health Organization (WHO) shared interim results that the Solidarity Therapeutics Trial, the world’s largest randomized controlled trial on […]

World Health Organization Solidarity Trial: Remdesivir & Others of No Real Therapeutic Benefit
5 months ago
Share

Ireland Teams with WHO to Participate in Solidarity Trial & Allocates €2.4m to Support Hospitals Patient Recruitment Costs

The Irish government recently signed up to participate in a World Health Organization (WHO) research collaboration, which will lead to […]

Ireland Teams with WHO to Participate in Solidarity Trial & Allocates €2.4m to Support Hospital Patient Recruitment Costs
8 months ago
Share

India’s Authorities Approve Start of WHO Solidarity Trial in Gujarat India & Challenges at GMERs

The World Health Organization’s Solidarity Trial covering COVID-19 launches in Gujarat India at sites including SVP College in Ahmedabad, GMERs, […]

India’s Authorities Approve Start of WHO Solidarity Trial in Gujarat India & Challenges at GMERs
10 months ago
Share

WHO’s Solidarity Trial for COVID-19 Patients Approved in the Philippines: 20+ Hospitals Involved

The Philippines Department of Health reports they will commence participation in the large-scale COVID-19 clinical trial known as the Solidarity […]

WHO’s Solidarity Trial for COVID-19 Patients Approved in the Philippines 20+ Hospitals Involved
11 months ago
Share

More on the WHO SOLIDARITY Trial Targeting COVID-19: The ISRCTN Registry Listing

TrialSite News was able to secure a little more publicly available information about WHO’s COVID-19 public health emergency-driven SOLIDARITY trial. […]

More on the WHO SOLIDARITY Trial Targeting COVID-19 The ISRCTN Registry Listing
11 months ago
Share

WHO SOLIDARITY Trial Enrolls First Patient in Norway: The World Requests more Transparency

The SOLIDARITY trial, conceived of by the World Health Organization and sponsored by Oslo University Hospital in Norway, enrolled its […]

WHO SOLIDARITY Trial Enrolls First Patient in Norway The World Requests more Transparency
11 months ago
Share

WHO Launches Global Megatrial of the Four Most Promising Coronavirus Treatments

On Friday March 20, 2020, the World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out […]

WHO Launches Global Megatrial of the Four Most Promising Coronavirus Treatments
12 months ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.